Lupin’s generic Benicar launches

Lupin’s generic Benicar launches

MUMBAI and BALTIMORE — Lupin on Monday launched its generic of Benicar (olmesartan medoxomil) tablets, having earlier received approval from the Food and Drug Administration. The drug is indicated to treat hypertension, alone or in combination with other hypertensive agents, to lower blood pressure.

Lupin’s generic will be available in 5-, 20- and 40-mg dosage strengths. The drug had U.S. sales of $681 million for the 12 months ended July 2017, according to QuintilesIMS data.